SCOTTSDALE, AZ -- (MARKET WIRE) -- February 28, 2007 -- Medistem Laboratories’ (OTCBB: MDSM) (FRANKFURT: S2U) Thomas Ichim, Chief of Scientific Development, was invited to talk at the 4th Annual Regenerative Medicine Organization Conference in Las Vegas on the subject of “Intellectual Property in Biotechnology.”
